Changes in Lean Tissue Mass, Fat Mass, Biological Parameters and Resting Energy Expenditure over 24 Months Following Sleeve Gastrectomy
Nutrients · 12 authors, 7 centres
AI SUMMARY
FIDELITY 100%
POPULATIONAdults with severe obesity (BMI >40 or ≥35 kg/m² with comorbidities) eligible for sleeve gastrectomy.
INTERVENTIONSleeve gastrectomy (SG).
COMPARISONLongitudinal comparisons within the same patients over time (baseline, 1, 12, and 24 months post-surgery).
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This longitudinal cohort study assessed body composition and metabolic changes in 83 patients for up to 24 months after sleeve gastrectomy, finding that fat mass loss was progressive over 12 months while lean tissue mass loss was concentrated in the first month. The study's main limitation is the high attrition rate, with only 60 of 83 patients completing the 24-month follow-up.
Full summary
1,552 CHARS
This longitudinal study investigated the kinetics of body composition and metabolic changes in obese patients following sleeve gastrectomy (SG). The background notes that while weight loss is a common metric, changes in fat mass (FM) and lean tissue mass (LTM) are more clinically relevant. The study followed 83 patients (mostly women) with measurements at baseline, 1, 12, and 24 months post-SG. Key results showed significant weight loss (~29% at 12 and 24 months). The change in body composition followed a biphasic pattern: an acute, concomitant loss of FM and LTM in the first month (both ~8-10% reduction), followed by a more sustained FM loss over 12 months (total ~42.7% reduction in whole-body FM) versus a lesser LTM loss (~19.4%). Visceral adipose tissue (VAT) decreased progressively. Biological markers improved, with reductions in CRP, HOMA-IR, and HbA1c. IGF-1 initially decreased but increased above baseline by 12 months, while IGFBP-3 remained lower. Resting energy expenditure (REE) decreased by 23.2% at 12 months and stabilized. Importantly, no significant further loss in FM, LTM, or metabolic parameters occurred between 12 and 24 months. A primary limitation is the high dropout rate, with only 60 patients completing the 24-month assessment. The study did not collect detailed data on diet or physical activity. The implications suggest that the first month post-surgery is critical for LTM loss, and strategies to preserve muscle mass during this period may be important for long-term metabolic health and weight maintenance.
PICO
PPOPULATION
Adults with severe obesity (BMI >40 or ≥35 kg/m² with comorbidities) eligible for sleeve gastrectomy.
IINTERVENTION
Sleeve gastrectomy (SG).
OOUTCOME
Changes in fat mass (FM), lean tissue mass (LTM), visceral adipose tissue (VAT), biological parameters (e.g., IGF-1, CRP, HOMA-IR), and resting energy expenditure (REE).